text: Aurobindo Pharma said it "has received final approval from the US Food and Drug Administration (USFDA) to manufacture Esomeprazole Magnesium Delayed-Release Capsules OTC, 20mg".
  Source: The Economic Times Healthcare and Biotech News - October 17, 2017 Category: Pharmaceuticals Source Type: news
  By HANS DUVEFELT Leo Dufour is not a diabetic. He is in his mid 50s, a light smoker with hypertension and a known hiatal hernia. He has had occasional heartburn and has taken famotidine for a few years along with his blood pressure and cholesterol pills. Over the past few months, he started to experience a lot more heartburn, belching and bloating. Adding pantoprazole did nothing for him. I referred him to a local surgeon who did an upper endoscopy. This did not reveal much, except some retained food in his stomach. A gastric emptying study showed severe gastroparesis. The surgeon offered him a trial of metoclopra...
  Source: The Health Care Blog - September 16, 2021 Category: Consumer Health News Authors: Christina Liu Tags: Medical Practice Physicians Primary Care Hans Duvefelt Source Type: blogs
  IJERPH, Vol. 18, Pages 9465: Estimated Cancer Risks Associated with Nitrosamine Contamination in Commonly Used Medications
  Schmitz Sandy Many nitrosamines are potent carcinogens, with more than 30 listed under California's Proposition 65. Recently, nitrosamine contamination of commonly used drugs for treatment of hypertension, heartburn, and type 2 diabetes has prompted numerous Food and Drug Administration (FDA) recalls in the US. These contaminants include the carcinogens NDMA (N-nitrosodimethylamine) and NDEA (N-nitrosodiethylamine) and the animal tumorigen NMBA (N-nitroso-N-methyl-4-aminobutyric acid). NMBA and NDEA are metabolically and/or structurally related to NDMA, an N-nitrosomethyl-n-alkylamine (NMA), and 12 other c...
  Source: International Journal of Environmental Research and Public Health - September 8, 2021 Category: Environmental Health Authors: Li Ricker Tsai Hsieh Osborne Sun Marder Elmore Schmitz Sandy Tags: Communication Source Type: research
  (Natural News) A woman from Ridgeway, Virginia, is the latest to file a lawsuit against the makers of heartburn medication Zantac, claiming that the drug gave her esophageal cancer. Deborah Haskins said that she began using Zantac in 2005, taking at least one 75mg tablet a day. She was later diagnosed with esophageal cancer, apparently due...
  Source: NaturalNews.com - August 26, 2021 Category: Consumer Health News Source Type: news
  Cancer: The common health complaint that can signal you're at risk of the deadly disease
  HEARTBURN is a burning feeling in the chest caused by stomach acid travelling up towards the throat. In some instances, the condition could signal cancer.
  Source: Daily Express - Health - August 25, 2021 Category: Consumer Health News Source Type: news
  Taking steps to combat acid reflux can help minimize the use of potentially dangerous drugs.
  Source: NYT Health - August 23, 2021 Category: Consumer Health News Authors: Jane E. Brody Tags: Gastroesophageal Reflux (Acid Reflux) Heartburn Content Type: Service Diet and Nutrition Obesity Weight Exercise Smoking and Tobacco Source Type: news
  In the early days of the COVID-19 pandemic, doctors in Wuhan noticed something surprising. Many of the elderly patients who survived the virus were poor: not exactly the demographic you would expect to fare well in a health crisis. A review of the survivors' medical records revealed that a significant number suffered from chronic heartburn and were taking an inexpensive drug called famotidine, the key ingredient in Pepcid.
  Source: World Pharma News - August 20, 2021 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
  Effect of Sodium Alginate on Gastrointestinal Symptoms after Esophagogastroduodenoscopy with Biopsy: Randomized Controlled Trial
  This study investigated the effect of sodium alginate on biopsy-related gastrointestinal symptoms.METHODS: In this open-label, randomized, controlled trial, patients undergoing EGD with biopsy were randomly assigned to a treatment or control group. In the treatment group, sodium alginate was orally administered for 3 days after EGD. Patients completed questionnaires about their gastrointestinal symptoms at baseline (past week), the day after returning home, and after another 3 days. Gastrointestinal symptoms, including abdominal pain, epigastric pain/soreness, heartburn, acid reflux, nausea/vomiting, borborygmus, abdominal...
  Source: Gut and Liver - August 10, 2021 Category: Gastroenterology Authors: Su Youn Nam Sang Won Lee Seong Woo Jeon Yong Hwan Kwon Source Type: research
  Ineffective esophageal motility in Chicago Classification version 4.0 better predicts abnormal acid exposure
  This study aims to investigate the clinical significance of IEM in CCv4.0 in the context of gastroesophageal reflux disease (GERD).MethodsA retrospective study was conducted among suspected GERD patients who had heartburn and/or regurgitation as their chief complaints and completed esophageal function tests in our center from 2017 to 2019. Patients were further grouped as "CCv3.0 IEM" and normal motility according to Chicago Classification version 3.0 (CCv3.0), and as "CCv4.0 IEM" and normal motility according to CCv4.0. The clinical characteristics, high-resolution manometry, esophageal reflux moni...
  Source: Esophagus - August 10, 2021 Category: Gastroenterology Source Type: research
  A 29-Year-Old Woman With Cough, Dry Eyes, Pulmonary Cysts, and Nodules
  Chest. 2021 Aug;160(2):e195-e198. doi: 10.1016/j.chest.2021.02.051.ABSTRACTA 29-year-old woman who is a never smoker and has a medical history of systemic hypertension presented with a 3-week history of generalized fatigue and dry cough. She endorsed sicca symptoms of dry eyes and dry mouth. She denied breathlessness, fever, chills, night sweats, or weight loss. She had no heartburn, postnasal drip, joint pain, swelling, or skin lesions. She had no known lung disease or history of pneumothorax. Her family history was unremarkable.PMID:34366044 | DOI:10.1016/j.chest.2021.02.051
  Source: Chest - August 9, 2021 Category: Respiratory Medicine Authors: Mohamed Omballi Aliaksandr Ramaniuk Divya C Patel Ali Ataya Source Type: research
  PedsQL™ Gastroparesis Symptoms Module Domain and Item Development: Qualitative Methods
  Conclusions: Our study supports the content validity of the new PedsQL Gastroparesis Symptoms Module. The Module field test study will be conducted in a multisite national study.
  Source: Journal of Pediatric Gastroenterology and Nutrition - August 1, 2021 Category: Gastroenterology Tags: Original Articles: Gastroenterology Source Type: research
  More News: Biotechnology | Esomeprazole | Food and Drug Administration (FDA) | Heartburn | Magnesium | Nexium | Pharmaceuticals